[go: up one dir, main page]

HUE055246T2 - Folyékony humán fibrinogén készítmény - Google Patents

Folyékony humán fibrinogén készítmény

Info

Publication number
HUE055246T2
HUE055246T2 HUE17837979A HUE17837979A HUE055246T2 HU E055246 T2 HUE055246 T2 HU E055246T2 HU E17837979 A HUE17837979 A HU E17837979A HU E17837979 A HUE17837979 A HU E17837979A HU E055246 T2 HUE055246 T2 HU E055246T2
Authority
HU
Hungary
Prior art keywords
human fibrinogen
liquid human
fibrinogen preparation
preparation
liquid
Prior art date
Application number
HUE17837979A
Other languages
English (en)
Inventor
Clemence Debraize
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Publication of HUE055246T2 publication Critical patent/HUE055246T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE17837979A 2016-12-22 2017-12-22 Folyékony humán fibrinogén készítmény HUE055246T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1663181A FR3061020B1 (fr) 2016-12-22 2016-12-22 Composition de fibrinogene humain

Publications (1)

Publication Number Publication Date
HUE055246T2 true HUE055246T2 (hu) 2021-11-29

Family

ID=58358663

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17837979A HUE055246T2 (hu) 2016-12-22 2017-12-22 Folyékony humán fibrinogén készítmény

Country Status (17)

Country Link
US (1) US20200093896A1 (hu)
EP (1) EP3558381B1 (hu)
CN (2) CN110087689B (hu)
CY (1) CY1124609T1 (hu)
DK (1) DK3558381T3 (hu)
ES (1) ES2877848T3 (hu)
FR (1) FR3061020B1 (hu)
HR (1) HRP20210984T1 (hu)
HU (1) HUE055246T2 (hu)
LT (1) LT3558381T (hu)
MX (2) MX379566B (hu)
PL (1) PL3558381T3 (hu)
PT (1) PT3558381T (hu)
RS (1) RS62103B1 (hu)
SI (1) SI3558381T1 (hu)
SM (1) SMT202100369T1 (hu)
WO (1) WO2018115800A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12030918B2 (en) * 2019-12-06 2024-07-09 University Of Wyoming Fibrin particles and methods of forming fibrin particles
JP2024529107A (ja) 2021-08-13 2024-08-01 ビオテスト・アクチエンゲゼルシャフト フィブリノゲン組成物および調製方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE336207C (de) 1916-03-05 1921-04-28 Siemens & Halske Akt Ges Vermittlungsvorrichtung fuer Fernsprechleitungen
DE69930653T2 (de) 1998-09-24 2007-01-25 Pharming Intellectual Property Bv Reinigung von fibrinogen aus milch durch den einsatz von kationenaustauschchromatographie
ES2267289T3 (es) 1998-09-24 2007-03-01 Pharming Intellectual Property Bv Purificacion de fibrinogeno a partir de fluidos mediante precipitacion y cromatografia de interaccion hidrofoba.
DE10261126A1 (de) * 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
WO2008117746A1 (ja) * 2007-03-22 2008-10-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 固体状フィブリノゲン製剤
WO2009134130A2 (en) * 2008-05-02 2009-11-05 Pharming Intellectual Property Bv Treatment of bleeding with low half-life fibrinogen
CN101371921B (zh) * 2008-10-08 2013-02-13 余美伦 一种速溶冻干纤维蛋白原和凝血酶制剂组合物、制备方法及其用途
CN102286095B (zh) * 2011-07-06 2013-08-21 大田华灿生物科技有限公司 纤维蛋白原的制备方法
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines

Also Published As

Publication number Publication date
EP3558381B1 (fr) 2021-04-07
DK3558381T3 (da) 2021-06-28
FR3061020A1 (fr) 2018-06-29
RS62103B1 (sr) 2021-08-31
MX379566B (es) 2025-03-11
HRP20210984T1 (hr) 2021-09-17
CN117180406A (zh) 2023-12-08
ES2877848T3 (es) 2021-11-17
PL3558381T3 (pl) 2021-10-25
PT3558381T (pt) 2021-07-01
CN110087689A (zh) 2019-08-02
FR3061020B1 (fr) 2019-05-17
MX2021001361A (es) 2021-04-13
SI3558381T1 (sl) 2021-11-30
SMT202100369T1 (it) 2021-09-14
CY1124609T1 (el) 2022-07-22
MX2019007608A (es) 2019-08-29
LT3558381T (lt) 2021-08-10
EP3558381A1 (fr) 2019-10-30
CN110087689B (zh) 2023-09-29
WO2018115800A1 (fr) 2018-06-28
US20200093896A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
HK1256839A1 (zh) 臨床製劑
DK3474804T3 (da) Medicinsk forbinding
EP3522966A4 (en) PATIENT INTERFACES
EP3485790A4 (en) CLEANING DEVICE
LT3479819T (lt) Stabilus skystas vaistinis preparatas
LT3426226T (lt) Oftalmologinė kompozicija
DK3474802T3 (da) Medicinsk forbinding
BR112016026879A2 (pt) Composição farmacêutica líquida
DK3494962T3 (da) Flydende inhalationsformulering omfattende RPL554
EP3536211A4 (en) CLEANING DEVICE
DK3532029T3 (da) Flydende farmaceutisk sammensætning
EP3424940A4 (en) Radiolabeled drug
DK3496551T3 (da) Flydende allulosesammensætning
EP3512460A4 (en) BLOOD VESSELS OBTAINED BY ENGINEERING
HUE050779T2 (hu) Folyékony gyógyszerészeti készítmény
DK3373874T4 (da) Medicinsk forbinding
EP3246047C0 (en) COMBINATION MEDICATION
DK3474803T3 (da) Medicinsk forbinding
EP3562368A4 (en) CLEANING DEVICE
EP3406230C0 (en) Cannula
HUE055246T2 (hu) Folyékony humán fibrinogén készítmény
HUE066130T2 (hu) Duddingtonia flagranst tartalmazó készítmény
DK3359102T3 (da) Medicinsk plaster
HUE054775T2 (hu) Benzidamint tartalmazó gyógyászati készítmény
UA34174S (uk) Пробка медична